Table 4

Risk of OAC and HGD–OAC by drug class by daily dose on data pooled on patient-level

Drug exposureDose categoryOAC onlyHGD–OAC
Case N (%)Control N (%)ORmatched (95% CI)p ValueCase N (%)Control N (%)ORmatched (95% CI)p Value
Total45 (100)732 (100)57 (100)1409 (100)
NSAID None32 (71)566 (77)Ref44 (77)1159 (82)Ref
<0.8 DDD per day3 (7)39 (5)1.1 (0.3 to 3.7)0.9093 (5)107 (8)0.6 (0.2 to 2.2)0.475
≥0.8 to <1.2 DDD per day4 (9)74 (10)0.9 (0.3 to 2.5)0.7834 (7)84 (6)0.8 (0.3 to 2.3)0.633
≥1.2 DDD per day6 (13)53 (7)2.2 (0.8 to 5.6)0.1116 (11)59 (4)1.9 (0.8 to 5.0)0.160
StatinNone33 (73)479 (65)Ref42 (74)1050 (75)Ref
<0.8 DDD per day8 (18)126 (17)0.9 (0.4 to 2.2)0.8809 (16)174 (12)1.0 (0.5 to 2.1)0.959
≥0.8 to <1.2 DDD per day1 (2)49 (7)0.3 (0.05 to 2.6)0.3052 (4)62 (4)0.7 (0.2 to 3.1)0.637
≥1.2 DDD per day3 (7)78 (11)0.7 (0.2 to 2.3)0.5194 (7)123 (9)0.8 (0.3 to 2.4)0.731
PPINone5 (11)103 (14)Ref11 (19)450 (32)Ref
<0.8 DDD per day9 (20)168 (23)0.9 (0.3 to 3.0)0.91411 (19)196 (14)1.1 (0.4 to 2.8)0.910
≥0.8 to <1.2 DDD per day23 (51)315 (43)1.2 (0.4 to 3.4)0.72327 (47)454 (32)1.1 (0.5 to 2.6)0.768
≥1.2 DDD per day8 (18)146 (20)1.1 (0.4 to 3.6)0.8228 (14)309 (22)0.9 (0.3 to 2.3)0.813
SSRINone40 (89)679 (93)Ref52 (91)1344 (95)Ref
<0.8 DDD per day1 (2)8 (1)3.0 (0.4 to 25.4)0.3171 (2)8 (1)3 (0.3 to 25.1)0.321
≥0.8 to <1.2 DDD per day4 (9)32 (4)2.3 (0.7 to 7.1)0.1494 (7)44 (3)2.0 (0.7 to 6.0)0.218
≥1.2 DDD per day0 (0)13 (2)0.9870 (0)13 (1)0.987
  • DDD, defined daily dose; HGD, high-grade dysplasia; NSAID, non-steroidal anti-inflammatory drugs; OAC, oesophageal adenocarcinoma; PPIs, proton pump inhibitors; SSRIs, selective serotonin re-uptake inhibitors.